Experience38+ Years
LevelLeadership
Executive Overview
At Haleon, we have purpose to deliver better everyday health with humanity. Our portfolio includes of some of the world’s most trusted brands including Sensodyne, Voltaren, Advil and Centrum. I moved to GSK in 2015 after ten years at Novartis, having started my career journey at P&G. In July 2022, Haleon separated from GSK and became a standalone listed company on the London Stock Exchange (HLN.L) with a secondary listing on the NYSE (HLN). I am currently Board member of Mondelẽz International, Inc.
Career Timeline
- Mondelēz InternationalCurrentFeb 2024–Present· 2 yrs 7 mos
- Member, Board of DirectorsCurrentFeb 2024–Oct 2025
- HaleonCurrentJul 2022–Present· 4 yrs 2 mos
- Chief Executive OfficerCurrentJul 2022–Present
- 2017–2020· 3 yrs
- Board of Trustees2017–2020
- Mar 2015–Jul 2022· 7 yrs 4 mos
- CEO Consumer Healthcare JVOct 2016–Jul 2022
- Head of Europe & AmericasMar 2015–Sep 2016
- 2004–2015· 11 yrs
- Division Head OTC; President Americas; President Europe2004–2015
- 1988–2004· 16 yrs
- Various roles in Marketing and Supply Chain1988–2004
Education
MBA
Finance
University of Cincinnati
BS
Electrical Engineering
Union CollegeExecutive Relationship Map
Reports To
Brian McNamara
Vice Chair & President
Chief Financial Officer
Chief Technology Officer
Chief Operating Officer
Skills & Expertise
Strategic LeadershipP&L ManagementProduct LaunchManagementConsumer healthcareStrategyConsumer ProductsCross-functional Team LeadershipCompetitive AnalysisManufacturingCustomer InsightGlobal MarketingPharmaceutical Industry